Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation - PubMed
- ️Fri Jan 01 2016
Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation
Amadin A Olotu et al. Virol J. 2016.
Abstract
Background: Hepatitis B virus (HBV) transmission through blood transfusion is reduced by screening for hepatitis B surface antigen (HBsAg). However this method cannot detect the presence of occult hepatitis B virus infection. This study sought to determine the prevalence of occult hepatitis B virus infection among blood donors in Ile-Ife, Nigeria. For the first time in Nigeria we employed an automated real-time PCR- method to investigate the prevalence of occult HBV in blood donors.
Methods: Blood donors screened with HBsAg immunochromatographic rapid test kits at the blood transfusion units of two hospitals and found to be negative were recruited into the study. Questionnaires to elicit risk factors for HBV infection were administered and then 10 ml of blood was collected from each donor. Plasma samples obtained from these HBsAg negative blood donors were screened again for HBsAg using an enzyme-linked immunosorbent assay (ELISA) method, and those found negative were screened for the presence of total antibody to the HBV core antigen (anti-HBc) using ELISA method. Those positive to anti-HBc were then tested for HBV DNA, using an automated real-time PCR method.
Results: Five hundred and seven blood donors found HBsAg negative by immunochromatographic rapid test kits at both blood transfusion units, were tested for HBsAg using ELISA and 5 (1 %) were HBsAg positive. The 502 found negative were tested for anti-HBc and 354 (70.5 %) were found positive implying previous exposure to HBV and 19 (5.4 %) of the 354 anti-HBc positive had HBV DNA signifying occult HBV infection. No risk factors were found to be associated with the presence of HBV DNA among those who tested positive.
Conclusion: Occult HBV infection exists in blood donors in Ile-Ife, Nigeria and the use of HBsAg alone for screening prospective donors will not eliminate the risk of HBV transmission in blood transfusion or stem cell transplantation.
Keywords: Anti-HBc; Blood donors; HBV DNA; HBsAg; Occult hepatitis B Virus.
Figures

Summary of Results. Figure one summarizes the laboratory tests done and the results seen in form of a flow chart. There were 507 subjects and their plasma specimens were screened for HBsAg using ELISA and five were positive. The remaining 502 were then screened for anti-HBc also using ELISA and 354 were found to be positive. The 354 anti-HBc samples were then screened for HBV DNA using real time PCR. HBV DNA was found in 19. (HBV – Hepatitis B virus, HBsAg –Hepatitis B surface Antigen Anti-HBc – antibody to hepatitis B core antigen, ELISA – Enzyme linked immunosorbent assay, PCR – Polymerase chain reaction)
Similar articles
-
Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z, Milani S, Sharifi Z. Alizadeh Z, et al. Arch Iran Med. 2014 Feb;17(2):106-7. Arch Iran Med. 2014. PMID: 24527970
-
Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR; SIMTI study group for HBV infection among first-time blood donors. Romanò L, et al. Blood Transfus. 2013 Apr;11(2):281-8. doi: 10.2450/2012.0160-12. Epub 2013 Jan 23. Blood Transfus. 2013. PMID: 23399361 Free PMC article.
-
Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.
Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Fopa D, et al. Blood Transfus. 2019 Nov;17(6):403-408. doi: 10.2450/2019.0182-19. Blood Transfus. 2019. PMID: 31846605 Free PMC article. Clinical Trial.
-
Kuhns MC, Busch MP. Kuhns MC, et al. Mol Diagn Ther. 2006;10(2):77-91. doi: 10.1007/BF03256447. Mol Diagn Ther. 2006. PMID: 16669606 Review.
-
Occult hepatitis B virus infection.
Allain JP. Allain JP. Transfus Clin Biol. 2004 Feb;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. Transfus Clin Biol. 2004. PMID: 14980545 Review.
Cited by
-
Nnachi OC, Uzor C, Umeokonkwo CD, Onwe EO, Okoye AE, Ewah RL, Nwani FO. Nnachi OC, et al. Anemia. 2022 Mar 17;2022:2622291. doi: 10.1155/2022/2622291. eCollection 2022. Anemia. 2022. PMID: 35340624 Free PMC article.
-
Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors.
Tung TT, Schmid J, Nghia VX, Cao LC, Linh LTK, Rungsung I, Sy BT, My TN, The NT, Hoan NX, Meyer CG, Wedemeyer H, Kremsner PG, Toan NL, Song LH, Bock CT, Velavan TP. Tung TT, et al. Pathogens. 2022 Dec 13;11(12):1524. doi: 10.3390/pathogens11121524. Pathogens. 2022. PMID: 36558858 Free PMC article.
-
Occult HBV Infection in Nigeria.
Akintule OA, Olusola BA, Odaibo GN, Olaleye DO. Akintule OA, et al. Arch Basic Appl Med. 2018 Feb;6(1):87-93. Epub 2018 May 4. Arch Basic Appl Med. 2018. PMID: 29963604 Free PMC article.
-
Fasola FA, Fowotade AA, Faneye AO. Fasola FA, et al. Afr Health Sci. 2021 Sep;21(3):1141-1147. doi: 10.4314/ahs.v21i3.22. Afr Health Sci. 2021. PMID: 35222576 Free PMC article.
-
Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review.
Bazie MM, Sanou M, Djigma FW, Compaore TR, Obiri-Yeboah D, Kabamba B, Nagalo BM, Simpore J, Ouédraogo R. Bazie MM, et al. World J Hepatol. 2024 May 27;16(5):843-859. doi: 10.4254/wjh.v16.i5.843. World J Hepatol. 2024. PMID: 38818293 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical